ARTICLE SUMMARY:
Thanks to several recent positive trials, endovascular clot retrieval devices are emerging as the new standard-of-care for the treatment of selected ischemic stroke patients. But with a limited number of US hospitals and physicians currently offering this therapy, it will take a significant, coordinated effort to expand access to all patients who could benefit. In this exclusive interview, The MedTech Strategist speaks with Brett Wall, VP and president of Neurovascular at Medtronic plc.
The stroke treatment community is embarking upon a fundamental transformation as endovascular clot retrieval devices gain standard-of-care status for selected patients suffering from a large-vessel ischemic stroke.
